Background/Objectives. Although onabotulinumtoxinA (BoNTA) is an established therapy for chronic migraine (CM), its effectiveness in high-frequency episodic migraine (HFEM) remains uncertain. We conducted an 18-year, single-center, retrospective study of patients treated with BoNTA for CM or HFEM. Methods. We included...
F. Jiménez-Jiménez, Alba Cárcamo-Fonfría, Silvina Espada-Rubio et al.· Pharmaceuticals· 0 citations
Objectives: Several lines of evidence point to a potential involvement of oxidative stress in the pathophysiology of multiple sclerosis (MS). Superoxide dismutase isoenzymes 1 and 2 (SOD1 and SOD2) and catalase (CAT) are key components of the enzymatic antioxidant defense system. Consequently, genetic variation in the...
E. García-Martín, J. Gómez-Tabales, J. Agúndez et al.· Biomolecules· 0 citations
Genotype frequencies of the MIR155 rs767649, under codominant, dominant, recessive, and overdominant inheritance models, as well as allelic frequencies, showed no significant differences between PD patients and healthy controls, and the age at PD onset did not differ among the three MIR-155 rs767649 genotypes.
H. Alonso-Navarro, S. Ladera-Navarro, P. Ayuso et al.· International Journal of Mol...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.